BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 32464191)

  • 1. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F.
    Zhao X; Liu Z; Ren Z; Wang H; Wang Z; Zhai J; Cao D; Lyu S; Li L; Lang R; He Q
    Eur J Pharmacol; 2020 Aug; 880():173225. PubMed ID: 32464191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
    Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
    J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide: progress on research in pharmacodynamics and toxicology.
    Li XJ; Jiang ZZ; Zhang LY
    J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1/CD147/MMPs pathway.
    Yuan S; Wang L; Chen X; Fan B; Yuan Q; Zhang H; Yang D; Wang S
    Biomed Pharmacother; 2016 Dec; 84():1776-1782. PubMed ID: 27847199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription.
    Wang B; Ma L; Tao X; Lipsky PE
    Arthritis Rheum; 2004 Sep; 50(9):2995-303. PubMed ID: 15457469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced progress of main pharmacology activities of triptolide].
    Cui J; Chen X; Su JC
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2655-2658. PubMed ID: 29098818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis of human pancreatic cancer cells induced by Triptolide.
    Zhou GX; Ding XL; Huang JF; Zhang H; Wu SB; Cheng JP; Wei Q
    World J Gastroenterol; 2008 Mar; 14(10):1504-9. PubMed ID: 18330938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
    Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
    PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Pharmacological Mechanisms of
    Huang B; Huang C; Zhu L; Xie L; Wang Y; Zhu N
    Biomed Res Int; 2021; 2021():5575621. PubMed ID: 34435046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.
    Johnson SM; Wang X; Evers BM
    J Surg Res; 2011 Jun; 168(2):197-205. PubMed ID: 19922946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts.
    Lin N; Sato T; Ito A
    Arthritis Rheum; 2001 Sep; 44(9):2193-200. PubMed ID: 11592385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
    Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
    Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Based on Network Pharmacology Tools to Investigate the Mechanism of
    Xia M; Liu D; Liu H; Zhao J; Tang C; Chen G; Liu Y; Liu H
    Front Med (Lausanne); 2021; 8():794962. PubMed ID: 34977095
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.
    Qiu D; Kao PN
    Drugs R D; 2003; 4(1):1-18. PubMed ID: 12568630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders.
    Liu X; Lin L; Lv T; Lu L; Li X; Han Y; Qiu Z; Li X; Li Y; Song X; Cao W; Li T
    Phytomedicine; 2022 Jul; 101():154103. PubMed ID: 35468451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.
    Tao X; Schulze-Koops H; Ma L; Cai J; Mao Y; Lipsky PE
    Arthritis Rheum; 1998 Jan; 41(1):130-8. PubMed ID: 9433878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of
    Xu X; Yu Y; Yang L; Wang B; Fan Y; Ruan B; Zhang X; Dai H; Mei W; Jie W; Zheng S
    Front Pharmacol; 2023; 14():1079539. PubMed ID: 36937875
    [No Abstract]   [Full Text] [Related]  

  • 18. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F.
    Chen BJ
    Leuk Lymphoma; 2001 Jul; 42(3):253-65. PubMed ID: 11699390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
    Lin Y; Peng N; Li J; Zhuang H; Hua ZC
    Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
    Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
    Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.